Uterine pathologies to be considered before uterus-preserving surgery in cases of uterine prolapse

Fatma Eskicioğu; Beyhan Özyurt

doi:10.5799/ahinjs.01.2015.04.0550

Uterine pathologies to be considered before uterus-preserving surgery in cases of uterine prolapse

Abstract

Objective: Investigation of unpredictable risks due to abnormal uterine pathology after the choice of uterus-preserving reconstructive surgical procedure for women who have uterine prolapse and no other complaints was aimed.

Methods: The data of 121 women (105 postmenopausal and 16 premenopausal) who underwent vaginal hysterectomy due to pelvic organ prolapse was examined and the post-hysterectomy histopathology results were evaluated.

Results: Senile cystic atrophy was the most common endometrial pathology result among postmenopausal women (63.5%). However, proliferative and secretory endometrium was the most common endometrial pathology finding among premenopausal women (81.3%). There were statistically significant differences between postmenopausal and perimenopausal women in terms of these pathology results (p<0.001). While, there was no difference between groups in terms of endometrial polyps, hyperplasia and adenomyosis (p>0.05), myoma uteri was significantly more common in patients with perimenopause (p=0.01).

Conclusion: The uterus must be evaluated in terms of endometrial pathologies in asymptomatic women with pelvic organ prolapse before uterus-preserving reconstructive surgical procedure, especially in postmenopausal period. J Clin Exp Invest 2015; 6 (4): 443-446

Key words: Pelvic organ prolapse, vaginal hysterectomy, endometrium

Keywords

Pelvik organ prolapsusu, vajinal histerektomi, endometrium

References

Baden WF, Walker TA. Genesis of the vaginal profile: a correlated classification of vaginal relaxation. Clin Obstet Gynecol 1972;15:1048-1054.
Handa VL, Garrett E, Hendrix S, et al. Progression and remission of pelvic organ prolapse: a longitudinal study of menopausal women. Am J Obstet Gynecol. 2004;190:27-32.
Okonkwo JE, Obiechina NJ, Obionu CN. Incidence of pelvic organ prolapse in Nigerian women. J Natl Med Assoc 2003;95:132-136.
Olsen AL, Smith VJ, Bergstrom JO, et al. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 1997;89:501–506.
Woodman PJ, Swift SE, O’Boyle AL, et al. Prevalence of severe pelvic organ prolapse in relation to job description and socioeconomic status: a multicenter cross-sectional study. Int Urogynecol J Pelvic Floor Dysfunct 2006;17:340-345.
MacLennan AH, Taylor AW, DH Wilson, Wilson D. The prevalence of pelvic floor disorders and their relationship to gender, age, parity and mode of delivery.BJOG 2000;107:1460–1470.
Jackson SR, Avery NC, Tarlton JF, et al. Changes in metabolism of collagen in genitourinary prolapse. Lancet 1996;347:1658–1661.
Chiaffarino F, Chatenoud L, Dindelli M, et al. Reproductive factors, family history, occupation and risk of urogenital prolapse. Eur J Obstet Gynecol Reprod Biol 1999;82:63–67.

Jelovsek JE, Maher C, Barber MD. Pelvic organ prolapse. Lancet 2007;369:1027–1038.
Olsen AL, Smith VJ, Bergstrom JO, et al. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 1997;89:501–506.
Fialkow MF, Newton KM, Lentz GM, Weiss NS. Lifetime risk of surgical management for pelvic organ prolapse or urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2008;19:437–440.
Costantini E, Lazzeri M. What part does mesh play in urogenital prolapse management today? Curr Opin Urol 2015;25:300-304.
Maher C, Baessler K, Glazener CM, et al. Surgical management of pelvic organ prolapse in women: a short version Cochrane review. Neurourol Urodyn 2008;27:3-12.
Bump RC, Mattiasson A, Bø K, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. American Journal of Obstetrics and Gynecology 1996;175:10-17.
Lousquy R, Costa P, Delmas V, Haab F. [Update on the epidemiology of genital prolapse]. Prog Urol 2009;19:907-915.
Chow D, Rodríguez LV. Epidemiology and prevalence of pelvic organ prolapse. Curr Opin Urol 2013;23:293-298.
Chung da J, Bai SW. Roles of sex steroid receptors and cell cycle regulation in pathogenesis of pelvic organ prolapse. Curr Opin Obstet Gynecol 2006;18:551-554.
Chen HY, Wan L, Chung YW, et al. Estrogen receptor beta gene haplotype is associated with pelvic organ prolapse. Eur J Obstet Gynecol Reprod Biol 2008;138:105-109.
Chen HY, Chung YW, Lin WY, et al. Progesterone receptor
polymorphism is associated with pelvic organ prolapse risk. Acta Obstet Gynecol Scand 2009;88:835-838.
Mingels MJ, Geels YP, Pijnenborg JM, et al. Histopathologic
assessment of the entire endometrium in asymptomatic women. Hum Pathol 2013;44:2293-2301.
Dreisler E, Poulsen LG, Antonsen SL, et al. EMAS clinical guide: Asessment of the endometrium in peri and postmenopausal women. Maturitas 2013;75:181-190.
Maruo T, Ohara N, Wang J, Matsuo H. Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Reprod 2004;10:207-220.
Ferenczy A. Pathophysiology of adenomyosis. Hum Reprod Update 1998;4:312-322.
Frick AC, Walters MD, Larkin KS, Barber MD. Risk of unanticipated abnormal gynecologic pathology at thetime of ysterectomy for uterovaginal prolapse. Am J Obstet Gynecol. 2010;202:507.
Jones R NHJ, Healy JC, King LJ, et al. Pelvic connective tissue resilience decreases with vaginal delivery,menopause and uterine prolapse. Br J Surg 2003;90:466-472.
Sivridis E, Giatromanolaki A. Proliferative activity in postmenopausal endometrium: the lurking potential for giving rise to an endometrial adenocarcinoma. J Clin Pathol 2004;57:840-844.
Modugno F, Ness RB, Chen C, Weiss NS. Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev 2005;14:2840-2847.
Wallace AE, Gibson DA, Saunders PT, Jabbour HN.Inflammatory events in endometrial adenocarcinoma.J Endocrinol 2010;206:141-157.
Bohoussou E, Adjoussou SA, Letouzey V, et al.[Should we perform intra-operative endometrial biopsy during pelvic reconstructive surgery with uterine preservation?]. J Gynecol Obstet Biol Reprod (Paris) 2014;43:40-45.
Sherman ME. Theories of endometrial carcinogenesis:a multidisciplinary approach. Mod Pathol 2000;13:295-308.

Details

Primary Language

Turkish

Subjects

-

Journal Section

-

Authors

Fatma Eskicioğu

Beyhan Özyurt This is me

Publication Date

January 3, 2016

Submission Date

January 3, 2016

Acceptance Date

-

Published in Issue

Year 2015 Volume: 6 Number: 4

DOI

https://doi.org/10.5799/ahinjs.01.2015.04.0550

IZ

https://izlik.org/JA54AH49YL

Cite

RIS / Bibtex

APA

Eskicioğu, F., & Özyurt, B. (2016). Uterine pathologies to be considered before uterus-preserving surgery in cases of uterine prolapse. Journal of Clinical and Experimental Investigations, 6(4), 364-368. https://doi.org/10.5799/ahinjs.01.2015.04.0550

AMA

1.Eskicioğu F, Özyurt B. Uterine pathologies to be considered before uterus-preserving surgery in cases of uterine prolapse. J Clin Exp Invest. 2016;6(4):364-368. doi:10.5799/ahinjs.01.2015.04.0550

Chicago

Eskicioğu, Fatma, and Beyhan Özyurt. 2016. “Uterine Pathologies to Be Considered before Uterus-Preserving Surgery in Cases of Uterine Prolapse”. Journal of Clinical and Experimental Investigations 6 (4): 364-68. https://doi.org/10.5799/ahinjs.01.2015.04.0550.

EndNote

Eskicioğu F, Özyurt B (January 1, 2016) Uterine pathologies to be considered before uterus-preserving surgery in cases of uterine prolapse. Journal of Clinical and Experimental Investigations 6 4 364–368.

IEEE

[1]F. Eskicioğu and B. Özyurt, “Uterine pathologies to be considered before uterus-preserving surgery in cases of uterine prolapse”, J Clin Exp Invest, vol. 6, no. 4, pp. 364–368, Jan. 2016, doi: 10.5799/ahinjs.01.2015.04.0550.

ISNAD

Eskicioğu, Fatma - Özyurt, Beyhan. “Uterine Pathologies to Be Considered before Uterus-Preserving Surgery in Cases of Uterine Prolapse”. Journal of Clinical and Experimental Investigations 6/4 (January 1, 2016): 364-368. https://doi.org/10.5799/ahinjs.01.2015.04.0550.

JAMA

1.Eskicioğu F, Özyurt B. Uterine pathologies to be considered before uterus-preserving surgery in cases of uterine prolapse. J Clin Exp Invest. 2016;6:364–368.

MLA

Eskicioğu, Fatma, and Beyhan Özyurt. “Uterine Pathologies to Be Considered before Uterus-Preserving Surgery in Cases of Uterine Prolapse”. Journal of Clinical and Experimental Investigations, vol. 6, no. 4, Jan. 2016, pp. 364-8, doi:10.5799/ahinjs.01.2015.04.0550.

Vancouver

1.Fatma Eskicioğu, Beyhan Özyurt. Uterine pathologies to be considered before uterus-preserving surgery in cases of uterine prolapse. J Clin Exp Invest. 2016 Jan. 1;6(4):364-8. doi:10.5799/ahinjs.01.2015.04.0550